Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
KDventures ABLTS:0P3C 31 EV-to-OCF is -5.04 as of Sep. 01, 2026. GuruFocus rates LTS:0P3C with a GF Score™ of 31/100 and a GF Value™ of kr0.70 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 1,408 Biotechnology companies, KDventures AB ranks worse than 54.76% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, KDventures AB's Enterprise Value is kr119.53 Mil.
KDventures AB's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was kr-23.72 Mil. Therefore, KDventures AB's EV-to-OCF for today is -5.04.
The historical rank and industry rank for KDventures AB's EV-to-OCF or its related term are showing as below:
LTS:0P3C'
s EV-to-OCF Range Over the Past 10 Years
Min: -116.42 Med: -9.71 Max: 352.79
Current: -5.04
During the past 13 years, the highest EV-to-OCF of KDventures AB was 352.79. The lowest was -116.42. And the median was -9.71.
LTS:0P3C's EV-to-OCF is ranked worse than 54.76% of 1408
companies
in the Biotechnology industry
Industry Median: -3.685
vs LTS:0P3C: -5.04
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
KDventures AB's PE Ratio (TTM) for today is calculated as:
KDventures AB's share price for today is kr0.238.
KDventures AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-0.616.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
KDventures AB EV-to-OCF Related Terms
KDventures AB EV-to-OCF Historical Data
* Premium members only.
The historical data trend for KDventures AB's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LTS:0P3C vs VRTX, REGN, MRNA: EV-to-OCF Comparison
For the Biotechnology subindustry, KDventures AB's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
KDventures AB EV-to-OCF vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, KDventures AB's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where KDventures AB's EV-to-OCF falls into.
KDventures AB's current Enterprise Value is kr119.53 Mil.
KDventures AB's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-23.72 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KDventures AB (LTS:0P3C) has a EV-to-OCF of -5.04 as of Sep. 01, 2026. According to the industry distribution chart, KDventures AB ranks #771 out of 1408 companies in the Biotechnology industry, placing it in the top 54.8%.
Is KDventures AB's EV-to-OCF too high?
KDventures AB's current EV-to-OCF is -5.04. Based on the distribution chart, KDventures AB ranks #771 out of 1408 companies in the Biotechnology industry, which is below the industry midpoint. Overall, KDventures AB has a GF Score™ of 31/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does KDventures AB's EV-to-OCF compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, KDventures AB ranks #771 out of 1408 companies for EV-to-OCF. This places KDventures AB in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Biotechnology company?
A good EV-to-OCF depends on the Biotechnology industry context. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. KDventures AB's current EV-to-OCF is -5.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KDventures AB stock overvalued right now?
Based on GuruFocus' analysis, KDventures AB (LTS:0P3C) is currently considered Possible Value Trap. The stock's GF Value™ is kr0.70, compared to a current price of kr0.24 — trading 66% below its estimated fair value. The current EV-to-OCF is -5.04. KDventures AB's overall GF Score™ is 31/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For KDventures AB (LTS:0P3C), the current EV-to-OCF is -5.04 as of Sep. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is KDventures AB (LTS:0P3C) Overvalued in 2026?
Based on GuruFocus' analysis, KDventures AB stock appears to be undervalued.
The current stock price of kr0.24 is trading 66% below its estimated GF Value™ of kr0.70.
GuruFocus considers KDventures AB to be Possible Value Trap.
Key valuation signals for LTS:0P3C:
EV-to-OCF: -5.04
GF Value™: kr0.70 vs. price of kr0.24 (66% below fair value)
No single metric tells the full story. See the LTS:0P3C stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
KDventures AB is a Nordic investment company specialized in life sciences. The company identifies and invests in pharmaceutical projects and medical technology products originating from research institutions in the Nordic region. Through a diversified portfolio across various stages of development, professional due diligence, and active board engagement, the company creates value from early research to commercialization. The company offers investors exposure to both listed and private life science projects with value growth potential.
31GF Score
Get the complete analysis for LTS:0P3C
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0P3C has been successfully added to your 
